BACKGROUND: We hypothesized that due to the absence of a dietary source of omega-3 fatty acids, the essential fatty acid (EFA) deficiency model leads to an overestimate of linoleic acid (LA) requirements. METHODS: over 7wk, young rats consumed an EFA diet containing either 0en% linoleate (0LA) and 0en% α-linolenate (0LNA) or a diet containing 0.5en% LNA plus one of seven levels of added LA (0.12-4.0en%; n=6/group). RESULTS: Rats consuming the 0LA-0LNA diet had the lowest final body weight, 34-68% lower LA and arachidonate in plasma and liver, 87% lower LA in epididymal fat, and an 8-20 fold higher eicosatrienoate in plasma, liver and muscle lipids. 0.5LNA completely prevented the lower growth and partly prevented the rise in eicosatrienoate seen in the 0LA-0LNA group. CONCLUSION: Providing dietary LNA at 0.5 en% reduces the rat's physiological requirement for LA by an estimated factor of at least four (0.5en% instead of 2en%). Since LA requirements in humans are also based on the same flawed model of EFA deficiency, it is plausible that they too have been overestimated and should therefore be reinvestigated. Copyright Â
BACKGROUND: We hypothesized that due to the absence of a dietary source of omega-3 fatty acids, the essential fatty acid (EFA) deficiency model leads to an overestimate of linoleic acid (LA) requirements. METHODS: over 7wk, young rats consumed an EFA diet containing either 0en% linoleate (0LA) and 0en% α-linolenate (0LNA) or a diet containing 0.5en% LNA plus one of seven levels of added LA (0.12-4.0en%; n=6/group). RESULTS:Rats consuming the 0LA-0LNA diet had the lowest final body weight, 34-68% lower LA and arachidonate in plasma and liver, 87% lower LA in epididymal fat, and an 8-20 fold higher eicosatrienoate in plasma, liver and muscle lipids. 0.5LNA completely prevented the lower growth and partly prevented the rise in eicosatrienoate seen in the 0LA-0LNA group. CONCLUSION: Providing dietary LNA at 0.5 en% reduces the rat's physiological requirement for LA by an estimated factor of at least four (0.5en% instead of 2en%). Since LA requirements in humans are also based on the same flawed model of EFA deficiency, it is plausible that they too have been overestimated and should therefore be reinvestigated. Copyright Â
Authors: Ameer Y Taha; Yewon Cheon; Keturah F Faurot; Beth Macintosh; Sharon F Majchrzak-Hong; J Douglas Mann; Joseph R Hibbeln; Amit Ringel; Christopher E Ramsden Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2014-02-24 Impact factor: 4.006
Authors: Christopher E Ramsden; Anthony F Domenichiello; Zhi-Xin Yuan; Matthew R Sapio; Gregory S Keyes; Santosh K Mishra; Jacklyn R Gross; Sharon Majchrzak-Hong; Daisy Zamora; Mark S Horowitz; John M Davis; Alexander V Sorokin; Amit Dey; Danielle M LaPaglia; Joshua J Wheeler; Michael R Vasko; Nehal N Mehta; Andrew J Mannes; Michael J Iadarola Journal: Sci Signal Date: 2017-08-22 Impact factor: 8.192
Authors: Lauren E Lin; Chuck T Chen; Kayla D Hildebrand; Zhen Liu; Kathryn E Hopperton; Richard P Bazinet Journal: J Lipid Res Date: 2014-12-04 Impact factor: 5.922
Authors: Ameer Y Taha; Helene C Blanchard; Yewon Cheon; Epolia Ramadan; Mei Chen; Lisa Chang; Stanley I Rapoport Journal: Mol Neurobiol Date: 2016-06-23 Impact factor: 5.590
Authors: Christopher E Ramsden; Amit Ringel; Ariel E Feldstein; Ameer Y Taha; Beth A MacIntosh; Joseph R Hibbeln; Sharon F Majchrzak-Hong; Keturah R Faurot; Stanley I Rapoport; Yewon Cheon; Yoon-Mi Chung; Michael Berk; J Douglas Mann Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2012-09-05 Impact factor: 4.006
Authors: Christopher E Ramsden; Daisy Zamora; Sharon Majchrzak-Hong; Keturah R Faurot; Steven K Broste; Robert P Frantz; John M Davis; Amit Ringel; Chirayath M Suchindran; Joseph R Hibbeln Journal: BMJ Date: 2016-04-12